ELV stock icon

Elevance Health
ELV

$535.29
1.19%
 

About: Elevance Health remains one of the leading health insurers in the U.S., providing medical benefits to 47 million medical members as of December 2023. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs such as Medicaid and Medicare Advantage plans, too.

Employees: 104,900

0
Funds holding %
of 6,702 funds
0
Analysts bullish %
of 21 analysts
0
News positive %
of 16 articles

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

20% more repeat investments, than reductions

Existing positions increased: 642 | Existing positions reduced: 536

8% more capital invested

Capital invested by funds: $97.9B [Q4 2023] → $105B (+$7.36B) [Q1 2024]

6% more funds holding in top 10

Funds holding in top 10: 48 [Q4 2023] → 51 (+3) [Q1 2024]

2% more call options, than puts

Call options by funds: $687M | Put options by funds: $673M

0% less funds holding

Funds holding: 1,616 [Q4 2023] → 1,610 (-6) [Q1 2024]

0.99% less ownership

Funds ownership: 88.41% [Q4 2023] → 87.41% (-0.99%) [Q1 2024]

4% less first-time investments, than exits

New positions opened: 150 | Existing positions closed: 156

Research analyst outlook

21 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$547
2%
upside
Avg. target
$591
10%
upside
High target
$646
21%
upside

21 analyst ratings

21 positive
100%
neutral
0%
negative
0%
Morgan Stanley
Erin Wright
20%upside
$643
Overweight
Initiated
24 Jun 2024
Cantor Fitzgerald
Sarah James
12%upside
$600
Overweight
Reiterated
12 Jun 2024
Stephens & Co.
Scott Fidel
15%upside
$615
Overweight
Reiterated
11 Jun 2024
B of A Securities
Kevin Fischbeck
21%upside
$646
Buy
Maintained
4 Jun 2024
JP Morgan
Lisa Gill
18%upside
$631
Overweight
Maintained
30 May 2024

Financial journalist opinion

Based on 16 articles about ELV published over the past 30 days